KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Non-Current Liabilities (2016 - 2025)

Charles River Laboratories International has reported Total Non-Current Liabilities over the past 17 years, most recently at $3.8 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 1.02% year-over-year to $3.8 billion; the TTM value through Dec 2025 reached $3.8 billion, down 1.02%, while the annual FY2025 figure was $3.8 billion, 1.02% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $3.8 billion at Charles River Laboratories International, down from $3.9 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $4.6 billion in Q2 2022 and troughed at $3.4 billion in Q1 2021.
  • A 5-year average of $4.1 billion and a median of $4.2 billion in 2021 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 33.34% in 2021 and later decreased 11.31% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $4.2 billion in 2021, then grew by 5.13% to $4.4 billion in 2022, then dropped by 2.08% to $4.3 billion in 2023, then dropped by 11.31% to $3.8 billion in 2024, then decreased by 1.02% to $3.8 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CRL at $3.8 billion in Q4 2025, $3.9 billion in Q3 2025, and $4.0 billion in Q2 2025.